These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16611918)

  • 21. A Small Molecule Inhibitor Selectively Induces Apoptosis in Cells Transformed by High Risk Human Papilloma Viruses.
    Sheaffer AK; Lee MS; Qi H; Chaniewski S; Zheng X; Farr GA; Esposito K; Harden D; Lei M; Schweizer L; Friborg J; Agler M; McPhee F; Gentles R; Beno BR; Chupak L; Mason S
    PLoS One; 2016; 11(6):e0155909. PubMed ID: 27280728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53.
    Scheffner M; Werness BA; Huibregtse JM; Levine AJ; Howley PM
    Cell; 1990 Dec; 63(6):1129-36. PubMed ID: 2175676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The E8 repression domain can replace the E2 transactivation domain for growth inhibition of HeLa cells by papillomavirus E2 proteins.
    Stubenrauch F; Straub E; Fertey J; Iftner T
    Int J Cancer; 2007 Nov; 121(10):2284-92. PubMed ID: 17583574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
    Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
    J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
    Thomas M; Pim D; Banks L
    Oncogene; 1999 Dec; 18(53):7690-700. PubMed ID: 10618709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types.
    Thomas M; Banks L
    J Gen Virol; 1999 Jun; 80 ( Pt 6)():1513-1517. PubMed ID: 10374970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of human papillomavirus type 18 (HPV-18) E6-mediated degradation of p53 in vitro and in vivo reveals significant differences based on p53 structure and cell type but little difference with respect to mutants of HPV-18 E6.
    Gardiol D; Banks L
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1963-70. PubMed ID: 9714244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
    Roeder GE; Parish JL; Stern PL; Gaston K
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6.
    Pim D; Banks L
    Oncogene; 1999 Dec; 18(52):7403-8. PubMed ID: 10602499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides.
    Stutz C; Reinz E; Honegger A; Bulkescher J; Schweizer J; Zanier K; Travé G; Lohrey C; Hoppe-Seyler K; Hoppe-Seyler F
    PLoS One; 2015; 10(7):e0132339. PubMed ID: 26151636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PKN binds and phosphorylates human papillomavirus E6 oncoprotein.
    Gao Q; Kumar A; Srinivasan S; Singh L; Mukai H; Ono Y; Wazer DE; Band V
    J Biol Chem; 2000 May; 275(20):14824-30. PubMed ID: 10809724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses.
    Kovelman R; Bilter GK; Glezer E; Tsou AY; Barbosa MS
    J Virol; 1996 Nov; 70(11):7549-60. PubMed ID: 8892874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the structure and DNA-binding properties of the E2 proteins from an oncogenic and a non-oncogenic human papillomavirus.
    Dell G; Wilkinson KW; Tranter R; Parish J; Leo Brady R; Gaston K
    J Mol Biol; 2003 Dec; 334(5):979-91. PubMed ID: 14643661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells.
    Havre PA; Yuan J; Hedrick L; Cho KR; Glazer PM
    Cancer Res; 1995 Oct; 55(19):4420-4. PubMed ID: 7671255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous papillomavirus E6 proteins must interact with p300 and block p53-mediated apoptosis for cellular immortalization and tumorigenesis.
    Muench P; Probst S; Schuetz J; Leiprecht N; Busch M; Wesselborg S; Stubenrauch F; Iftner T
    Cancer Res; 2010 Sep; 70(17):6913-24. PubMed ID: 20663910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two polymorphic variants of wild-type p53 differ biochemically and biologically.
    Thomas M; Kalita A; Labrecque S; Pim D; Banks L; Matlashewski G
    Mol Cell Biol; 1999 Feb; 19(2):1092-100. PubMed ID: 9891044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alternatively spliced HPV-18 E6* protein inhibits E6 mediated degradation of p53 and suppresses transformed cell growth.
    Pim D; Massimi P; Banks L
    Oncogene; 1997 Jul; 15(3):257-64. PubMed ID: 9233760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dispensability of p53 degradation for tumorigenicity and decreased serum requirement of human papillomavirus type 16 E6.
    Inoue T; Oka K; Yong-Il H; Vousden KH; Kyo S; Jing P; Hakura A; Yutsudo M
    Mol Carcinog; 1998 Mar; 21(3):215-22. PubMed ID: 9537653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure of High-Risk Papillomavirus 31 E6 Oncogenic Protein and Characterization of E6/E6AP/p53 Complex Formation.
    Conrady MC; Suarez I; Gogl G; Frecot DI; Bonhoure A; Kostmann C; Cousido-Siah A; Mitschler A; Lim J; Masson M; Iftner T; Stubenrauch F; Travé G; Simon C
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.